KHN-702

N/A

Report date: 2025/08/06 16:51:52
NME

Base Information

Drug NameKHN-702
Drug Alias NameKHN702KHN-702
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type X alpha subunit inhibitors
TargetsSodium channel protein type X alpha subunit
Therapy Area/IndicationsAcute PainPain, Postoperative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChengdu Kanghong Pharmaceutical Group Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChengdu Kanghong Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsAcute PainPain, Postoperative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A